http://www.biocryst.com
BioCryst Pharmaceuticals, Inc. Company Intro
BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).
Industry
Healthcare
BioCryst Pharmaceuticals, Inc. Headquaters
4505 Emperor Boulevard
Durham,27703
United States
BioCryst Pharmaceuticals, Inc. Share price
14 Sep 2022 08:44 GMT
$13.39
-0.39 (-2.83 %)
BioCryst Pharmaceuticals, Inc. Market cap
$2.562 B
WMC RANKING
2022
BioCryst Pharmaceuticals, Inc. # 132
BiotechnologyLatest BioCryst Pharmaceuticals, Inc. News
05 Oct 2022
Monitoring BioCryst Pharmaceuticals Inc. (BCRX) after recent ...
BioCryst Pharmaceuticals Inc.'s filing revealed that its Director ABERCROMBIE GEORGE B unloaded Company's shares for reported $55200.0 on Apr 18.
05 Oct 2022
Kalvista Stops Phase II HAE Prophylactic Trial Following Liver ...
KalVista Pharmaceuticals Inc has terminated a mid-stage trial of its ... competitive threat for BioCryst Pharmaceuticals, Inc.'s prophylactic plasma...
05 Oct 2022
Stock That Is Worth Exploring Now: BioCryst Pharmaceuticals ...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) does about 2.57M shares in volume on a normal day but saw 5400085 shares change hands in Tuesday trading.
WMC Market Score
WMC Market to Revenue Score
BioCryst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioCryst Pharmaceuticals, Inc. | USD | $32,048 | $209,674 | $-209,499 | $25,620B | 132 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BioCryst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| BioCryst Pharmaceuticals, Inc. | 0.35 | 4.68 | 0.01 | 0 | 0 | 0 | 2.18 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
